antibody therapies

‘New Omicron subvariant resistant to all antibody therapies’

The team of researchers from the Infection Biology Unit at the German Primate Center, Leibniz Institute for Primate Research and the Division of Molecular Immunology at the Friedrich-Alexander-University Erlangen-Nurnberg investigated how efficiently approved antibody therapies inhibit the currently circulating Omicron...